Trial Profile
Phase I and dose-finding study of TS-1 with Abraxane for metastatic breast cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 27 Sep 2011 New trial record